Abstract Library

#3234 Dissociated response as a new biomarker of treatment response in neuroendocrine tumors: Results from phase 3 of the RAISE project

Introduction: RAISE aimed to find a surrogate endpoint to early predict treatment efficacy in patients with neuroendocrine tumors (NET). Dissociated response is the inhomogeneous response of the different lesions of a patient. Its prognostic value remains unclear.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Dromain C

Authors: Dromain C, Pavel M, Ronot M, Schaefer N, Mandair D,

Keywords: neuroendocrine tumor, dissociated response, progression-free survival, prediction,

#3028 Pancreatic Neuroendocrine Neoplasms: Dissecting the Molecular Heterogeneity

Introduction: Pancreatic neuroendocrine neoplasms (PNENs) are a group of rare but biologically and clinically heterogeneous neoplasms with variable patient outcomes. Little is known about the molecular differences between PNENs and the biologic significance of such divergence.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Yang K, Kalloger S, Aird J, Lee M, Colborne S,

Keywords: Pancreatic neuroendocrine neoplasms, Exome, Transcriptome, Proteome,

#691 Pancreatic Focal Alpha Cell Hyperplasia with Hyperglucagonaemia without the Glucagonoma Syndrome

Introduction: Pancreatic alpha cell hyperplasia and hyperglucagonaemia without the glucagonoma syndrome is a rare clinical syndrome not widely recognised. Here we describe a novel mutation in the glucagon receptor gene (GCGR) in a patient with the disease.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Miller H, Baird D, Kidd M, Cohen P, Vlavianos P,

Keywords: glucagon receptor, mutation,